These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12448580)

  • 1. Bayesian approach to evaluation of bridging studies.
    Liu JP; Hsiao CF; Hsueh H
    J Biopharm Stat; 2002 Aug; 12(3):401-8. PubMed ID: 12448580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Bayesian noninferiority approach to evaluation of bridging studies.
    Liu JP; Hsueh H; Hsiao CF
    J Biopharm Stat; 2004 May; 14(2):291-300. PubMed ID: 15206527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of prior information for Bayesian evaluation of bridging studies.
    Hsiao CF; Hsu YY; Tsou HH; Liu JP
    J Biopharm Stat; 2007; 17(1):109-21. PubMed ID: 17219758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A group sequential approach to evaluation of bridging studies.
    Hsiao CF; Xu JZ; Liu JP
    J Biopharm Stat; 2003 Nov; 13(4):793-801. PubMed ID: 14584723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A two-stage design for bridging studies.
    Hsiao CF; Xu JZ; Liu JP
    J Biopharm Stat; 2005; 15(1):75-83. PubMed ID: 15702606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A consistency approach to evaluation of bridging studies and multi-regional trials.
    Tsou HH; Chien TY; Liu JP; Hsiao CF
    Stat Med; 2011 Jul; 30(17):2171-86. PubMed ID: 21590701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weighted evidence approach of bridging study.
    Tsou HH; Tsong Y; Liu JT; Dong X; Wu Y
    J Biopharm Stat; 2012 Sep; 22(5):952-65. PubMed ID: 22946942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bridging studies in clinical development.
    Liu JP; Chow SC
    J Biopharm Stat; 2002 Aug; 12(3):359-67. PubMed ID: 12448577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A predictive Bayesian approach to the design and analysis of bridging studies.
    Gould AL; Jin T; Zhang LX; Wang WW
    J Biopharm Stat; 2012 Sep; 22(5):916-34. PubMed ID: 22946940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and analysis of bridging studies with prior probabilities on the null and alternative hypotheses.
    Zeng D; Pan Z; Lin DY
    Biometrics; 2020 Mar; 76(1):224-234. PubMed ID: 31724739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Bayesian approach for inference from a bridging study with binary outcomes.
    Gandhi M; Mukherjee B; Biswas D
    J Biopharm Stat; 2012 Sep; 22(5):935-51. PubMed ID: 22946941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A note on two approaches of testing bridging evidence to a new region.
    Dong X; Guo Y; Tsong Y
    J Biopharm Stat; 2012 Sep; 22(5):966-76. PubMed ID: 22946943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A behavioural Bayes approach to the determination of sample size for clinical trials considering efficacy and safety: imbalanced sample size in treatment groups.
    Kikuchi T; Gittins J
    Stat Methods Med Res; 2011 Aug; 20(4):389-400. PubMed ID: 20223784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian sample size determination for a clinical trial with correlated continuous and binary outcomes.
    Stamey JD; Natanegara F; Seaman JW
    J Biopharm Stat; 2013; 23(4):790-803. PubMed ID: 23786161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical methods for bridging studies.
    Chow SC; Chiang C; Liu JP; Hsiao CF
    J Biopharm Stat; 2012 Sep; 22(5):903-15. PubMed ID: 22946939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance and sample size requirements of Bayesian methods for binary outcomes in fixed-dose combination drug studies.
    Holt MM; Stamey JD; Seaman JW; Young DM
    J Biopharm Stat; 2009; 19(1):120-32. PubMed ID: 19127471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of the bayesian prior information to evaluation of equivalence of similar biological medicinal products.
    Chiu ST; Liu JP; Chow SC
    J Biopharm Stat; 2014; 24(6):1254-63. PubMed ID: 25032488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample size determination for a specific region in a multiregional trial.
    Ko FS; Tsou HH; Liu JP; Hsiao CF
    J Biopharm Stat; 2010 Jul; 20(4):870-85. PubMed ID: 20496211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unified approach for extrapolation and bridging of adult information in early-phase dose-finding paediatric studies.
    Petit C; Samson A; Morita S; Ursino M; Guedj J; Jullien V; Comets E; Zohar S
    Stat Methods Med Res; 2018 Jun; 27(6):1860-1877. PubMed ID: 27705884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bridging bioequivalence studies.
    Liu JP
    J Biopharm Stat; 2004 Nov; 14(4):857-67. PubMed ID: 15587968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.